Tag: PCK
Residential aged care sector drives strong quarterly results for PainChek
Australian medical device company PainChek (ASX: PCK) has reported a strong performance for the March quarter with much of its growth being driven by the country’s residential aged care sector.
Pai...
PainChek grows number of licenced beds, triggers $1.25 million payment from federal government
Medical device company PainChek (ASX: PCK) confirmed it has met an important 25,000 licensed bed milestone under a $5 million grant agreement with the Australian federal government.
In total, PainChe...
PainChek expands UK presence with first orders of pain assessment technology
Australian medical device company PainChek (ASX: PCK) is expanding its presence in the UK market, making its first direct sale and confirming first orders for the region.
PainChek has developed a s...
PainChek prepares for Australian rollout of pain assessment software in residential aged care
Healthcare innovator PainChek (ASX: PCK) has announced that it intends to partner up with Ward Medication Management (Ward MM) to deliver a state-funded national roll-out of its pain assessment techno...
PainChek gets Singapore regulatory clearance, signs landmark deal with nation’s leading aged care provider
Australian medical device company PainChek (ASX: PCK) has advanced its international expansion strategy with receipt of a key regulatory clearance from Singapore’s Health Sciences Authority and the su...
PainChek partners with Australia’s largest child health research institute to trial pain app in infants
As part of its plan to expand its PainChek app to children worldwide, PainChek (ASX: PCK) has teamed up with the Melbourne Murdoch Children’s Research Institute to clinically test a version of the app...
PainChek expands internationally with Person Centred Software UK distribution agreement
PainChek (ASX: PCK) has secured a binding distribution agreement with Person Centred Software paving the way for the company to launch its pain assessment and monitoring technology into international ...
Federal Government to invest $5m in PainChek’s app for dementia patients
Australian medical device company PainChek (ASX: PCK) is set to receive a $5 million grant from the Australian Federal Government to trial its pain recognition and monitoring technology in the country...
PainChek signs licence agreement with Queensland aged care provider
Digital health company PainChek (ASX: PCK) has executed a licence agreement with Churches Of Christ in Queensland, which will give the aged care provider the ability to deploy the monitoring technolog...
PainChek receives ePAT validation in peer-reviewed study
PainChek’s (ASX: PCK) proprietary pain-detection product has been officially validated by a peer-reviewed study and in added support towards its overall clinical usefulness in detecting pain amongst n...
PainChek to secure FDA De Novo classification
Formerly ePat Technologies (ASX: EPT), medical device company PainChek (ASX: PCK) is on course to secure De Novo classification from the Food and Drug Administration (FDA) in the US — a relatively ne...
